OTC Markets EXMKT - Delayed Quote USD

Viveve Medical, Inc. (VIVE)

0.0001
0.0000
(0.00%)
At close: May 21 at 4:00:00 PM EDT
Loading Chart for VIVE
  • Previous Close 0.0000
  • Open 0.0002
  • Bid --
  • Ask --
  • Day's Range 0.0002 - 0.0002
  • 52 Week Range 0.0001 - 0.0200
  • Volume 250
  • Avg. Volume 1,421
  • Market Cap (intraday) 4,290
  • Beta (5Y Monthly) -59.62
  • PE Ratio (TTM) --
  • EPS (TTM) -0.6600
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Viveve Medical, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices for the non-invasive treatment of vaginal introital laxity, sexual function, vaginal rejuvenation, and stress urinary incontinence. The company offers Viveve System comprises of the radiofrequency generator, reusable handpiece, and treatment tip, as well as cryogen canister and other consumable components. It markets its products through sales employees and distributors in the United States, Canada, the Asia Pacific, Europe, the Middle East, Latin America, and internationally. Viveve Medical, Inc. was founded in 2005 and is headquartered in Englewood, Colorado.

www.viveve.com

47

Full Time Employees

December 31

Fiscal Year Ends

Recent News: VIVE

View More

Performance Overview: VIVE

Trailing total returns as of 5/21/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

VIVE
50.00%
S&P 500 (^GSPC)
0.63%

1-Year Return

VIVE
66.67%
S&P 500 (^GSPC)
9.83%

3-Year Return

VIVE
99.99%
S&P 500 (^GSPC)
49.81%

5-Year Return

VIVE
100.00%
S&P 500 (^GSPC)
98.22%

Compare To: VIVE

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: VIVE

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -62.13%

  • Return on Equity (ttm)

    -210.99%

  • Revenue (ttm)

    6.83M

  • Net Income Avi to Common (ttm)

    -28.14M

  • Diluted EPS (ttm)

    -0.6600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    5.91M

  • Total Debt/Equity (mrq)

    507.94%

  • Levered Free Cash Flow (ttm)

    -7.57M

Research Analysis: VIVE

View More

Company Insights: VIVE

Research Reports: VIVE

View More

People Also Watch